Modeling the dosage effect of oncogenes in leukemogenesis

Area of Science:

• Oncology
• Hematology
• Genetics

Background:

• Leukemogenesis involves oncogene activation and dosage.
• Mouse models are essential for studying human hematologic malignancies.
• Understanding precise oncogene function requires studying them at relevant expression levels.

Purpose of the Study:

• To review the dosage effects of oncogenes in leukemogenesis.
• To compare methods for modeling human hematologic malignancies in mice.
• To highlight the importance of cell type-specific, time-controlled, and dosage-relevant genetic manipulations.

Main Methods:

• Utilizing conditional gene expression systems for cell type-specific and time-controlled oncogene introduction.
• Employing bone marrow retroviral transduction and transplantation to target oncogenes into hematopoietic cells.
• Developing modified retroviral vectors with modulated transgene expression.

Main Results:

• Optimal oncogene dosage is critical for inducing mouse tumors that mimic human cancers.
• Specific oncogenes like PML/RARalpha and TEL/ABL efficiently induce leukemia in mice only at low or pathophysiologically relevant expression levels.
• Conditional gene expression and modified retroviral systems effectively model human cancer in mice.

Conclusions:

• Mouse models are invaluable for dissecting cancer pathogenesis, identifying therapeutic targets, and evaluating treatments.
• The timing and cell type of genetic lesions are critical for cancer development.
• Conditional gene expression and modified retroviral transduction systems are complementary tools for studying human cancers in mice.